EFS Bioproduction

EFS Bioproduction is the industrial and pharmaceutical division of the Établissement Français du Sang (the French National Blood Service), specializing in the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs). Operating primarily through its Atlantic Bio GMP facility, the organization serves as a Contract Development and Manufacturing Organization (CDMO) for both academic and industrial partners. Their expertise spans the production of cell therapies, gene therapies, and innovative products like exosomes and induced pluripotent stem cells (iPSCs). By leveraging its unique position within the national blood supply chain, EFS Bioproduction facilitates the transition of innovative therapies from laboratory research to clinical-grade production and commercialization.